CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Shares withheld for taxes Chief Legal Officer gave up 5,049 shares (to pay taxes)
- 4 Planned sale Chief Business Officer sold 1,159 shares at $3.15 ($3,651)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,586 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 4,103 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,422 shares (to pay taxes)
- 4 Grant or award Chief Scientific Officer acquired 28,200 shares (grant or award)
- 4 Shares withheld for taxes Chief Medical Officer gave up 5,145 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Grant or award Director acquired 3,757 shares (grant or award)
- 4 Grant or award Director acquired 3,074 shares (grant or award)
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 144 Insider Sale of Securities
- 424B3 Offering Prospectus
- 424B5 Offering Prospectus
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 7 of 28 · 549 filings